Hypoxia differentially regulates arterial and venous smooth muscle cell proliferation via PDGFR-β and VEGFR-2 expression

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 302, Issue 5, 2012, Pages

  Chanakira, Alice ^a   Dutta, Raini ^b   Charboneau, Richard ^a   Barke, Roderick ^a,b   Santilli, Steven M ^a,b   Roy, Sabita ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Graft patency; Platelet derived growth factor homodimer B; Vascular endothelial growth factor A

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; NEUTRALIZING ANTIBODY; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; VASCULOTROPIN RECEPTOR 2;

ARTERIAL DERIVED SMOOTH MUSCLE CELL; ARTERY MUSCLE; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; VEIN; VENOUS DERIVED SMOOTH MUSCLE CELL;

ARTERIES; CELL HYPOXIA; CELL LINE; CELL PROLIFERATION; HUMANS; MUSCLE, SMOOTH, VASCULAR; PROTO-ONCOGENE PROTEINS C-SIS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VEINS;

EID: 84857285894     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00411.2011     Document Type: Article

References (32)

1. Abedi H, Zachary I. Signalling mechanisms in the regulation of vascular cell migration. Cardiovasc Res 30: 544-556, 1995.
2. Abraham D, Distler O. How does endothelial cell injury start? The role of endothelin in systemic sclerosis. Arthritis Res Ther 9, Suppl 2: S2, 2007.
3. Achouh P, Boutekadjirt R, Toledano D, Hammoudi N, Pagny JY, Goube P, Isselmou KO, Lancelin B, Fouquet R, Acar C. Long-term (5- to 20-year) patency of the radial artery for coronary bypass grafting. J Thorac Cardiovasc Surg 140: 73-9, 79.e1-2, 2009.
4. Bjornheden T, Levin M, Evaldsson M, Wiklund O. Evidence of hypoxic areas within the arterial wall in vivo. Arterioscler Thromb Vasc Biol 19: 870-876, 1999.
5. Brogi E, Wu T, Namiki A, Isner JM. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90: 649-652, 1994.
6. Byrne AM, Bouchier-Hayes DJ, Harmey JH. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med 9: 777-794, 2005.
7. Cheng YF, Ou HY, Tsang LL, Yu CY, Huang TL, Chen TY, Concejero A, Wang CC, Wang SH, Lin TS, Liu YW, Yang CH, Yong CC, Chiu KW, Jawan B, Eng HL, Chen CL. Vascular stents in the management of portal venous complications in living donor liver transplantation. Am J Transplant 10: 1276-1283, 2010.
8. Cogo A, Napolitano G, Michoud MC, Barbon DR, Ward M, Martin JG. Effects of hypoxia on rat airway smooth muscle cell proliferation. J Appl Physiol 94: 1403-1409, 2003.
9. Conte MS. Molecular engineering of vein bypass grafts. J Vasc Surg 45, Suppl A: A74-81, 2007.
10. Dong LH, Wen JK, Miao SB, Jia Z, Hu HJ, Sun RH, Wu Y, Han M. Baicalin inhibits PDGF-BB-stimulated vascular smooth muscle cell proliferation through suppressing PDGFRbeta-ERK signaling and increase in p27 accumulation and prevents injury-induced neointimal hyperplasia. Cell Res 20: 1252-1262.
11. Faller DV. Endothelial cell responses to hypoxic stress. Clin Exp Pharmacol Physiol 26: 74-84, 1999.
12. Ferrara N, Winer J, Burton T. Aortic smooth muscle cells express and secrete vascular endothelial growth factor. Growth Factors 5: 141-148, 1991.
13. Growcott EJ, Banner KH, Wharton J. Hypoxia amplifies the proliferative capacity of distal human pulmonary artery smooth-muscle cells. Chest 128: 600S-601S, 2005.
14. Hacker TA, Griffin MO, Guttormsen B, Stoker S, Wolff MR. Plateletderived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo. J Invasive Cardiol 19: 269-274, 2007.
15. Helfrich I, Scheffrahn I, Bartling S, Weis J, von Felbert V, Middleton M, Kato M, Ergun S, Schadendorf D. Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma. J Exp Med 207: 491-503, 2010.
16. Hulten LM, Levin M. The role of hypoxia in atherosclerosis. Curr Opin Lipidol 20: 409-414, 2009.
17. Jo N, Mailhos C, Ju M, Cheung E, Bradley J, Nishijima K, Robinson GS, Adamis AP, Shima DT. Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization. Am J Pathol 168: 2036-2053, 2006.
18. Lee ES, Bauer GE, Caldwell MP, Santilli SM. Association of artery wall hypoxia and cellular proliferation at a vascular anastomosis. J Surg Res 91: 32-37, 2000.
19. Lee ES, Caldwell MP, Tretinyak AS, Santilli SM. Supplemental oxygen controls cellular proliferation and anastomotic intimal hyperplasia at a vascular graft-to-artery anastomosis in the rabbit. J Vasc Surg 33: 608-613, 2001.
20. Li L, Blumenthal DK, Masaki T, Terry CM, Cheung AK. Differential effects of imatinib on PDGF-induced proliferation and PDGF receptor signaling in human arterial and venous smooth muscle cells. J Cell Biochem 99: 1553-1563, 2006.
21. Murray CJ, Kulkarni SC, Ezzati M. Understanding the coronary heart disease versus total cardiovascular mortality paradox: a method to enhance the comparability of cardiovascular death statistics in the United States. Circulation 113: 2071-2081, 2006.
22. Muto A, Fitzgerald TN, Pimiento JM, Maloney SP, Teso D, Paszkowiak JJ, Westvik TS, Kudo FA, Nishibe T, Dardik A. Smooth muscle cell signal transduction: implications of vascular biology for vascular surgeons. J Vasc Surg 45, Suppl A: A15-A24, 2007.
23. Namiki A, Brogi E, Kearney M, Kim EA, Wu T, Couffinhal T, Varticovski L, Isner JM. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem 270: 31189-31195, 1995.
24. Osada-Oka M, Ikeda T, Imaoka S, Akiba S, Sato T. VEGF-enhanced proliferation under hypoxia by an autocrine mechanism in human vascular smooth muscle cells. J Atheroscler Thromb 15: 26-33, 2008.
25. Pak O, Aldashev A, Welsh D, Peacock A. The effects of hypoxia on the cells of the pulmonary vasculature. Eur Respir J 30: 364-372, 2007.
26. Pancholi S, Earle KA. Pattern of angiogenic cytokine release from human vascular smooth muscle cells programmed by amino acid deprivation. Cytokine 12: 1322-1325, 2000.
27. Ray JB, Arab S, Deng Y, Liu P, Penn L, Courtman DW, Ward ME. Oxygen regulation of arterial smooth muscle cell proliferation and survival. Am J Physiol Heart Circ Physiol 294: H839-H852, 2008.
28. Schultz K, Fanburg BL, Beasley D. Hypoxia and hypoxia-inducible factor-1_ promote growth factor-induced proliferation of human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 290: H2528-H2534, 2006.
29. Shibuya M, Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 312: 549-560, 2006.
30. Sirois MG, Plante GE, Farmer P, Sirois P. Platelet activating factor modulates peptidoleukotriene effects on the permeability of bovine aortic endothelial cell to albumin. Agents Actions 39 Spec No: C17-20, 1993.
31. Turner NA, Ho S, Warburton P, O'Regan DJ, Porter KE. Smooth muscle cells cultured from human saphenous vein exhibit increased proliferation, invasion, and mitogen-activated protein kinase activation in vitro compared with paired internal mammary artery cells. J Vasc Surg 45: 1022-1028, 2007.
32. Vorp DA, Lee PC, Wang DH, Makaroun MS, Nemoto EM, Ogawa S, Webster MW. Association of intraluminal thrombus in abdominal aortic aneurysm with local hypoxia and wall weakening. J Vasc Surg 34: 291-299, 2001.